Top Markets
Coin of the day
Immunotech Laboratories, Inc. Immunotech Laboratories, Inc.

Immunotech Laboratories, Inc.

IMMB
Rang in aandelen #40594
Immunotech Laboratories, Inc. develops and commercializes proprietary proteins... Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.
Aandeelprijs
$0.0002
Laatst gesynchroniseerd: 2026-08-12
Marktkapitalisatie
$114.99K
Verandering (1 dag)
0.00%
Verandering (1 jaar)
100.00%
Land
US
Handel Immunotech Laboratories, Inc. (IMMB)

Categorie

Koersgeschiedenis voor Immunotech Laboratories, Inc. (IMMB)
Hoogste slotkoers: $0.00 op 2026-08-01

Laagste slotkoers: $0.00 op 2022-03-01
Koersgeschiedenis van Immunotech Laboratories, Inc. van 2022 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 0.00%
2025 0.00%
2024 0.00%
2023 -40.00%
2022 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$517.18 30.63%
US
$857.76 32.66%
NL
$744.96 8.94%
CH
$1.08K -6.68%
KR
$259.89 16.65%
BE